Agios Pharmaceuticals
About:
Agios Pharmaceuticals is a biopharmaceutical company discovers and develops therapeutics in the field of cancer metabolism.
Website: https://www.agios.com
Twitter/X: agiospharma
Top Investors: Flagship Pioneering, Third Rock Ventures, ARCH Venture Partners, Celgene
Description:
Agios Pharmaceuticals is a biopharmaceutical company, discovers and develops therapeutics in the field of cancer metabolism. It also develops drugs that focus on glycolysis, fatty acid metabolism, and autophagy. The company's therapeutics are used in the areas of autoimmune, inflammatory, and neurological diseases. Agios Pharmaceuticals was formerly known as CANCER METABOLISM THERAPEUTICS And changed its name to Agios Pharmaceuticals In April 2008. The company is based in Cambridge, Massachusetts.
$776M
$10M to $50M
Cambridge, Massachusetts, United States
2008-01-01
info(AT)agios.com
Craig Thompson, Lewis C. Cantley, Shin-San Michael Su, Tak Mak
101-250
2019-11-07
Public
© 2025 bioDAO.ai